A groundbreaking medication , retatrutide, is creating considerable anticipation within the Oz weight control community. Created by the company, this dual GIP and GLP-1 agonist appears to provide more substantial results than current therapies. Initial medical trials have shown remarkable decreases in physical weight , suggesting a for a different